carbimazole has been researched along with Bright Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouatou, Y; de Seigneux, S; Mavrakanas, TA; Meyer, P; Samer, C | 1 |
| Aljama, P; Calañas-Continente, A; Espinosa, M; Lopez-Rubio, F; Manzano-García, G; Santamaría, R | 1 |
| Baker, LR; Chesser, AM; Comer, M; D'Cruz, D; Hurst, MJ; Lightowler, C; Raine, AE | 1 |
1 review(s) available for carbimazole and Bright Disease
| Article | Year |
|---|---|
Carbimazole-induced, ANCA-associated, crescentic glomerulonephritis: case report and literature review.
Topics: Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antithyroid Agents; Carbimazole; Glomerulonephritis; Graves Disease; Humans; Kidney Failure, Chronic; Male | 2013 |
2 other study(ies) available for carbimazole and Bright Disease
| Article | Year |
|---|---|
Necrotizing glomerulonephritis and pulmonary hemorrhage associated with carbimazole therapy.
Topics: Antithyroid Agents; Carbimazole; Creatinine; Female; Glomerulonephritis; Graves Disease; Hemorrhage; Humans; Kidney; Lung Diseases; Middle Aged; Necrosis; Radiography, Thoracic; Treatment Outcome | 2005 |
Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with anti-thyroid drug treatment.
Topics: Adult; Antibodies, Antineutrophil Cytoplasmic; Antithyroid Agents; Autoantibodies; Carbimazole; Glomerulonephritis; Humans; Hyperthyroidism; Kidney; Male; Middle Aged; Propylthiouracil; Thyrotoxicosis; Vasculitis | 1995 |